| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| aripiprazole | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist |
| aripiprazole | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist |
| aripiprazole | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist |
| aripiprazole | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,ligand |
| aripiprazole | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist, |
| aripiprazole | beta-1 adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | beta-2 adrenergic receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | dopamine d1 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,partial agonist,ligand |
| aripiprazole | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.83 | approved,investigational | antagonist,partial agonist,agonist |
| aripiprazole | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.83 | approved,investigational | antagonist,partial agonist |
| aripiprazole | dopamine d3 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,partial agonist |
| aripiprazole | dopamine d4 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,partial agonist |
| aripiprazole | dopamine d5 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,partial agonist,ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | glutamate (nmda) receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | histamine h1 receptor | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.08 | approved,investigational | antagonist |
| aripiprazole | histamine h2 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | histamine h3 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | histamine h4 receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.38 | approved,investigational | partial agonist |
| aripiprazole | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.38 | approved,investigational | partial agonist,agonist |
| aripiprazole | 5-hydroxytryptamine receptor 1b | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.18 | approved,investigational | antagonist,ligand,agonist |
| aripiprazole | 5-hydroxytryptamine receptor 1d | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.2 | approved,investigational | antagonist,ligand,agonist |
| aripiprazole | 5-hydroxytryptamine receptor 1e | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,ligand |
| aripiprazole | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.22 | approved,investigational | antagonist,partial agonist,agonist |
| aripiprazole | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.22 | approved,investigational | antagonist,partial agonist |
| aripiprazole | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | inverse agonist |
| aripiprazole | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
0.12 | approved,investigational | antagonist,partial agonist,agonist |
| aripiprazole | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist |
| aripiprazole | 5-hydroxytryptamine receptor 5a | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | 5-hydroxytryptamine receptor 6 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist |
| aripiprazole | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | antagonist,partial agonist |
| aripiprazole | delta-type opioid receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | kappa-type opioid receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | mu-type opioid receptor | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | ligand |
| aripiprazole | sodium-dependent dopamine transporter | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | modulator |
| aripiprazole | sodium-dependent serotonin transporter | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Irritable Mood[MeSHID:D007508] Unipolar Depression[MeSHID:D003866] Gilles de la Tourette syndrome[MeSHID:D005879] Autism Spectrum Disorders[MeSHID:D000067877] Pervasive Development Disorder[MeSHID:D002659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Porphyria Erythropoietic[MeSHID:D017092] |
NA | approved,investigational | modulator |
| click here to return to the previous page | ||||||||